NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
6.34
+0.62 (10.84%)
At close: Oct 28, 2026, 4:00 PM EDT
6.37
+0.03 (0.47%)
After-hours: Oct 28, 2026, 7:26 PM EDT
NextCure Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
40
Market Cap
29.02M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Immutep | 13.79M |
| Seres Therapeutics | 1.88M |
| Neuphoria Therapeutics | 1.17M |
| IGC Pharma | 1.11M |
| ABVC BioPharma | 797.92K |
NXTC News
- 2 months ago - Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001 - PRNewsWire
- 2 months ago - NextCure reports Q2 EPS ($2.80), consensus ($1.92) - TheFly
- 2 months ago - NextCure Quarterly report: Q2 2026 - Filings
- 2 months ago - NextCure Earnings release: Q2 2026 - Filings
- 2 months ago - NextCure Slides: Corporate presentation - Filings
- 3 months ago - NextCure trading resumes - TheFly
- 3 months ago - NextCure trading halted, volatility trading pause - TheFly
- 3 months ago - Why Is Penny Stock NextCure (NXTC) Up Today? - TipRanks